Molecular imaging of experimental atherosclerosis using anti-malondialdehyde-modified low-density lipoprotein humanised antibody fragment targeted nanoparticles

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Targeting lipids and lipid-related pathways in cardiovascular disease Vascular Diseases ESC Professional Premium Access ESC Congress 2022

ESC 365 is supported by

ESC 365 is supported by